Identify and comparatively analyse the views of users, medical professionals, general practitioners and pain management experts, pharmacists and addiction treatment providers on codeine use, misuse and dependence and relate these views to the efficacy and impact of current regulation on sales and dispensing practices, displacement between prescribed, OTC and illicitly sourced codeine on the Internet, development of initiatives targeting prescribed, OTC and online brief point of sale interventions, unmet referral and addiction treatment needs and targeted health promotion and in store tactics in Ireland, the UK and South Africa.
Conduct a systematic review and meta-analysis of international and national literature on prescribed, OTC and web sourced codeine use, misuse and dependence.
Develop a comparative profile of codeine product sales trends, and extent of prescribed, OTC and web sourced codeine use, misuse and dependence in Ireland, the UK and South Africa.
Identify and comparatively analyse the variant trajectories of non-dependant and dependent codeine use to be found amongst the public, referring to purchasing habits and patterns of use, misuse and dependency outcomes via prescribed, OTC and web-based retail sales in Ireland, the UK and South Africa.
Identify and comparatively analyse the public health impact of therapeutic and non-therapeutic codeine use, misuse and dependence via prescribed, OTC and web-based retail sales in Ireland, the UK and South Africa.
Create a model for use across the EU and South Africa in terms of customer tracking and monitoring systems, designed Internet and pharmacy based customer brief interventions, and continuing education material and session plans for medics, pharmacists, health promotion professionals and treatment providers on Rx’ed and OTC medicines of abuse. This model can be used for other identified medicines of abuse across the EU and South Africa.
Click below to download our current brochure. This file is supplied in PDF format and requires Acrobat ReaderDownload